Topiramate NDC 68462-371

NDC codes

FDA NDC Directory

Product NDC (as listed)68462-371Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68462-0371Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
68462-371-05	68462037105	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-371-05)Marketed from Feb 1, 2021
68462-371-30	68462037130	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-371-30)Marketed from Feb 1, 2021
68462-371-90	68462037190	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-371-90)Marketed from Feb 1, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Topiramate
Generic name (nonproprietary): topiramate
Active ingredients: Topiramate — 200 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Glenmark Pharmaceuticals Inc., USA
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210278
Marketing start: Feb 1, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 2C19 Inhibitors (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 68462-371_4a2276a1-54f6-4de6-8710-c2c088a23e76SPL ID 4a2276a1-54f6-4de6-8710-c2c088a23e76SPL set ID 54bfabce-1f8a-40ee-8b55-efce8fe6fbf1RxCUI 1494769, 1812419, 1812421, 1812425, 1812427UNII 0H73WJJ391UPC 0368462374306, 0368462371305, 0368462372302, 0368462373309

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468462037105 followed by a unit qualifier and the quantity

Package 68462-0371-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 30, 2026.

Indications (excerpt from the label)

Topiramate extended-release capsules are indicated for: • Epilepsy: initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older ( 1.1 ); adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut Syndrome in patients 2 years of age and older ( 1.2 ) • Preventive treatment of migraine in patients 12 years of age and older ( 1.3 ) 1.1 Monotherapy Epilepsy Topiramate extended-release capsules are indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210278

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210278
Product	Strength	Form · route	Labeler	Product NDC
Topiramate	Topiramate 100 mg/1	Capsule, Extended releaseOral	NorthStar RxLLC	72603-122
Topiramate	Topiramate 25 mg/1	Capsule, Extended releaseOral	NorthStar RxLLC	72603-120
Topiramate	Topiramate 50 mg/1	Capsule, Extended releaseOral	NorthStar RxLLC	72603-121
Topiramate	Topiramate 150 mg/1	Capsule, Extended releaseOral	NorthStar RxLLC	72603-123
Topiramate	Topiramate 200 mg/1	Capsule, Extended releaseOral	NorthStar RxLLC	72603-124
Topiramate	Topiramate 150 mg/1	Capsule, Extended releaseOral	Glenmark Pharmaceuticals Inc., USA	68462-370
Topiramate	Topiramate 100 mg/1	Capsule, Extended releaseOral	Glenmark Pharmaceuticals Inc., USA	68462-374
Topiramate	Topiramate 25 mg/1	Capsule, Extended releaseOral	Glenmark Pharmaceuticals Inc., USA	68462-372
Topiramate	Topiramate 50 mg/1	Capsule, Extended releaseOral	Glenmark Pharmaceuticals Inc., USA	68462-373